Comparison Guide
Private Credit vs Venture Debt
How private credit and venture debt compare on company stage, warrant dilution, facility structure, and growth profile requirements for mid-market and growth-stage borrowers.
Side-by-Side Comparison
How private credit and bank lending compare across key dimensions
| Attribute | Private Credit | Venture Debt |
|---|---|---|
| Target Company Stage | Profitable or PE-backed companies with established EBITDA; typically post-buyout or mature growth-stage businesses generating GBP 5m+ EBITDA | Series B-D venture-backed companies; pre-profit or early-profit businesses with strong revenue growth and institutional VC backing on the cap table |
| Underwriting Basis | Cash flow-based underwriting anchored to EBITDA multiples; lenders model debt service coverage, leverage ratios, and downside scenarios against historical earnings | Primarily underwritten against equity runway and the probability of a future fundraise; lenders assess the quality of existing VC investors, burn rate, and months of cash remaining |
| Warrant Coverage | No equity dilution; private credit lenders receive debt returns only through interest margin and OID, with no warrant or equity conversion component | Warrant coverage of 0.25%-2.0% of fully diluted equity is standard; warrants exercise at the most recent equity round price and represent material dilution for founders over multiple rounds of venture debt |
| Typical Facility Size | GBP 25m-500m+ for institutional direct lenders; sized as a multiple of EBITDA (typically 4.0x-6.5x) or against contracted revenue bases | GBP 3m-50m typically, sized as 25-35% of the most recent equity round; larger facilities available for late-stage companies with GBP 50m+ ARR but rare above GBP 75m |
| Maturity and Amortisation | 6-7 year bullet maturity with no amortisation in unitranche structures; borrower retains full use of capital throughout the facility life | 36-48 month tenor with 6-12 months interest-only followed by straight-line amortisation; effective use-of-proceeds window is 18-30 months before repayment pressure begins |
| Pricing (All-in Cost) | SONIA/EURIBOR + 500-700bps cash margin plus 1-2% OID; no equity component means total cost is fully deterministic at drawdown | 8-14% annualised interest rate plus warrant value; effective cost including dilution can reach 15-25%+ if the company achieves a strong exit, making it one of the most expensive forms of debt capital on a realised basis |
| Revenue Profile Required | Stable, predictable revenue with strong EBITDA margins; recurring revenue models preferred but not essential if cash conversion is demonstrated | High revenue growth rate (40-100%+ YoY) is the primary credit factor; lenders tolerate negative EBITDA and cash burn if the growth trajectory supports a future equity round or exit |
| Covenant Structure | Covenant-lite with springing leverage test on the RCF; wide EBITDA addback definitions; maintenance covenants rare in institutional direct lending | Financial covenants on minimum cash balance, minimum revenue run-rate, and sometimes ARR growth thresholds; milestone-based covenants tied to product or customer KPIs are increasingly common |
| Security Package | Comprehensive fixed and floating charge over all assets; share pledges over operating companies; assignment of material contracts and IP | First-priority lien over all assets including IP; venture debt lenders place particular emphasis on IP security given the asset-light nature of most venture-backed businesses |
| Lender Decision-Making | Single credit committee decision based on fundamental credit analysis; detailed financial model review with 4-6 week diligence process | Rapid underwriting in 2-4 weeks; lender relies heavily on the signalling value of the existing VC syndicate and the lead investor commitment to future rounds |
| Use of Proceeds | Acquisitions, leveraged buyouts, recapitalisations, dividend recaps, refinancings; the full spectrum of corporate and PE-sponsored transactions | Runway extension between equity rounds, bridge financing to profitability, specific growth initiatives (sales hiring, market expansion); generally not used for acquisitions or shareholder distributions |
| Refinancing Path | Refinancing into bank market at lower pricing once leverage reduces below 3.5x; or re-pricing with existing or new private credit lender on improved terms | Typically repaid from next equity round proceeds or from operating cash flows once profitability is achieved; refinancing into private credit or bank debt occurs at the transition from growth to mature-stage |
When Private Credit Is the Right Choice
Private credit is the natural financing solution for companies that have moved beyond the venture stage and can demonstrate consistent, underwritable cash flows. The following scenarios represent the core situations where direct lending is clearly preferable to venture debt, delivering lower total cost of capital and avoiding the equity dilution that makes venture debt economically unattractive for established businesses.
PE-backed portfolio companies requiring acquisition or recapitalisation financing. Once a private equity sponsor has acquired a platform company, the financing needs shift fundamentally from growth capital to leveraged debt. A PE-backed business with GBP 15m EBITDA seeking GBP 75m of acquisition debt has no reason to consider venture debt - the company has stable cash flows, institutional ownership, and a credit profile that direct lenders will underwrite at 5.0x leverage without requiring any equity dilution. The absence of warrants in private credit means the sponsor retains 100% of the equity upside, which can be worth tens of millions of pounds over a typical 4-5 year hold period. For a company that exits at 12x EBITDA, the 1-2% warrant coverage that a venture debt provider would have demanded could represent GBP 2m-4m of value transfer that was entirely avoidable through the private credit channel.
Profitable technology companies that have outgrown the venture ecosystem. Many technology businesses reach a stage where they are generating GBP 5m-20m of EBITDA, growing at 15-30% annually, and no longer need venture capital to fund operations. These companies sit in a financing gap: too mature for venture debt economics (where the warrant dilution is disproportionate to the risk), but potentially unfamiliar with the institutional private credit market. Direct lending provides these businesses with significant non-dilutive capital for acquisitions, international expansion, or shareholder liquidity events. A SaaS company with GBP 40m ARR and 25% EBITDA margins can access GBP 50m-75m of private credit on a recurring revenue multiple basis, preserving the founder equity that venture debt would have eroded.
Businesses with contracted or recurring revenue but limited equity investor appetite. Certain sectors - infrastructure services, B2B software with long contract durations, managed services businesses - generate highly predictable cash flows but lack the hypergrowth narrative that attracts venture investors. Venture debt is not a viable option because the underlying VC signalling is absent and the growth profile does not fit venture lender underwriting models. Private credit lenders, by contrast, are specifically attracted to predictable, contracted revenue streams and will structure term loans against this cash flow visibility at pricing that is 300-500bps cheaper than the effective cost of venture debt including dilution.
Companies seeking longer-dated capital without amortisation pressure. The 36-48 month tenor and mandatory amortisation of venture debt creates refinancing pressure within 18-24 months of drawdown. For businesses investing in multi-year growth initiatives - building out a European sales organisation, developing a new product platform, or executing a buy-and-build acquisition strategy - the 6-7 year bullet maturity of a private credit unitranche provides the time horizon needed to realise returns on invested capital. The absence of amortisation means the business retains full access to the drawn capital throughout the facility life, rather than seeing its available funding erode as principal repayments begin.
When Venture Debt Is the Right Choice
Venture debt serves a specific and valuable purpose in the capital structure of high-growth, venture-backed companies. In the following scenarios, venture debt is the more appropriate instrument despite its higher effective cost, because the alternatives - either additional equity dilution from a new funding round or private credit that the company cannot access - are worse outcomes for founders and existing shareholders.
Series B-D companies extending runway between equity rounds. The primary use case for venture debt remains runway extension. A Series C company that raised GBP 30m of equity six months ago can draw GBP 8m-10m of venture debt to extend its cash runway from 18 months to 24+ months, giving the business additional time to hit the milestones needed to raise a Series D at a higher valuation. The warrant dilution of 0.5-1.0% is dramatically less dilutive than raising an additional GBP 10m of equity at the current valuation, which might represent 5-8% of the company. In this context, venture debt is a tool for minimising total equity dilution across the funding lifecycle, and the warrant cost is the premium paid for that optionality.
Pre-profit companies with strong revenue growth but negative EBITDA. Private credit lenders underwrite against EBITDA and cash flow coverage ratios. A company growing revenue at 80% year-over-year but burning GBP 2m per month simply does not have the financial profile that direct lenders can underwrite. Venture debt lenders, by contrast, are specifically designed to assess these businesses - evaluating the quality of the VC syndicate, the trajectory toward profitability, the unit economics at scale, and the likelihood of a successful future fundraise. Until the company reaches profitability and can demonstrate 12+ months of positive EBITDA, venture debt is the only institutional debt product available.
Companies needing rapid, lightweight financing alongside a primary equity round. Venture debt can be arranged concurrently with an equity round, often by the same investment bank or the venture lender who has a pre-existing relationship with the lead VC. The underwriting process leverages the due diligence already completed for the equity round, enabling committed terms within 2-3 weeks. For a company closing a GBP 25m Series C that wants to supplement with GBP 7m of venture debt, the incremental process is minimal. Private credit would require a separate, parallel workstream with independent diligence, legal documentation, and credit committee approval - adding complexity and timeline to an already demanding transaction process.
Businesses in sectors where private credit has limited appetite. Certain venture-backed sectors - early-stage life sciences, deep tech, hardware-heavy businesses with unproven unit economics, or consumer platforms with high customer acquisition costs - fall outside the risk appetite of institutional direct lenders regardless of revenue scale. Venture debt providers specialising in these verticals have developed underwriting frameworks that accommodate the higher risk profile, typically requiring stronger VC backing and more conservative advance rates as compensation. A biotech company with promising Phase II trial data and GBP 20m of recent Series B funding may find venture debt the only non-dilutive capital available until clinical milestones de-risk the business sufficiently for private credit consideration.
Hybrid Structures: Combining Private Credit and Venture Debt Approaches
As companies transition from high-growth to mature-growth or profitability, a hybrid approach to debt financing can bridge the gap between venture debt and institutional private credit. These structures are particularly relevant for late-stage technology companies, venture-backed businesses approaching or achieving profitability, and PE-backed growth equity portfolio companies that retain some venture characteristics.
Recurring revenue facilities as a bridge between venture debt and private credit. A growing category of specialist lenders offers term loans underwritten against annual recurring revenue (ARR) multiples rather than traditional EBITDA multiples. These facilities - typically sized at 0.5x-1.5x ARR - are available to SaaS companies with GBP 10m+ ARR, even if EBITDA is minimal or slightly negative. The pricing (SONIA + 600-900bps with no warrants) sits between venture debt effective costs and traditional private credit margins, reflecting the transitional risk profile. This structure allows companies to escape the dilutive warrant economics of venture debt while they build toward the EBITDA thresholds that institutional direct lenders require. As the company scales toward 20%+ EBITDA margins, the facility can be refinanced into a conventional private credit unitranche at tighter pricing.
Growth equity financing with private credit characteristics. Several European credit funds have raised dedicated growth lending vehicles that blend elements of both markets. These facilities offer GBP 15m-75m of non-dilutive debt to companies with GBP 15m-100m revenue, positive unit economics, and a clear path to profitability within 12-24 months. Unlike venture debt, there are no warrants and the tenor extends to 4-5 years with limited or no amortisation. Unlike traditional private credit, the underwriting framework accommodates negative EBITDA if revenue quality and growth trajectory meet specific thresholds. This hybrid category has expanded significantly since 2023 as both venture debt providers and direct lenders have extended their mandates to capture the growing pool of late-stage, near-profitable technology companies that fall between traditional categories.
Sequential structuring across the company lifecycle. The most sophisticated capital structure planning treats venture debt and private credit as sequential instruments in a deliberate financing roadmap. A company might raise GBP 5m of venture debt alongside its Series B to extend runway, draw GBP 15m of recurring revenue-based growth debt as it reaches GBP 25m ARR and break-even, and then refinance into a GBP 60m private credit unitranche once EBITDA reaches GBP 8m-10m and a PE growth equity investor takes a significant stake. Each stage optimises the cost and structure of debt capital for the company stage, minimising total dilution across the lifecycle while maintaining continuous access to leverage. Advisers who understand both markets can plan this sequencing from the outset, ensuring that each facility is structured with refinancing optionality that facilitates the transition to the next stage.
Not Sure Which Route Fits?
We help borrowers evaluate financing options across bank lending, private credit, and hybrid structures. No obligation to proceed.
Compare Your OptionsDecision Framework
Use this checklist to determine which route fits your situation
Choose Private Credit When
- The company generates positive EBITDA of GBP 5m+ with demonstrated cash flow stability
- A PE sponsor or institutional investor is on the cap table providing governance and reporting infrastructure
- The financing need is for acquisition, recapitalisation, or dividend recap rather than runway extension
- Equity dilution through warrants is unacceptable given the current valuation and cap table
- A facility tenor of 5+ years with bullet maturity is required to support the business plan
- The business has moved beyond the venture stage and no longer relies on future equity fundraises
- Total facility size exceeds GBP 25m, justifying the institutional direct lending underwriting process
- The company operates in a sector where private credit lenders have established underwriting frameworks
Choose Bank Lending When
- The company is pre-profit with strong revenue growth but negative EBITDA and material cash burn
- Tier-1 venture capital investors are on the cap table and committed to supporting future rounds
- The primary purpose is extending runway between equity rounds to achieve higher next-round valuation
- Facility size requirement is GBP 3m-15m, below the minimum threshold for institutional direct lenders
- The company is in a rapid scaling phase where EBITDA-based underwriting cannot capture the growth trajectory
- Speed of execution is critical and the venture lender has a pre-existing relationship with the lead VC investor
- The sector (life sciences, deep tech, consumer) falls outside typical private credit risk appetite
- The company expects to repay the facility from proceeds of the next equity fundraise within 18-24 months
Tell Us About Your Transaction
Share your deal parameters and our team will map the lender landscape. Confidential, no-obligation.
Related Private Credit Pages
Explore more private credit topics
Private Credit for Software & Technology
How direct lenders underwrite recurring revenue and high-growth technology businesses across Europe.
CountryPrivate Credit in the United Kingdom
Market overview, active lenders, and deal characteristics for UK private credit transactions.
TransactionPrivate Credit for Acquisition Financing
Structuring private credit facilities for platform acquisitions, bolt-ons, and take-private transactions.
ComparisonPrivate Credit vs Bank Lending
Side-by-side comparison of private credit and traditional bank lending for European mid-market borrowers.
OverviewPrivate Credit Hub
Central resource for private credit sectors, geographies, transaction types, and comparison guides.
Frequently Asked Questions
Common questions about choosing between financing options
Let Us Find the Right Private Credit Solution
With access to 300+ lenders across Europe, we match borrowers with the capital structures that fit. Confidential, no-obligation initial conversation.
